Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
Bulevirtide is a novel antiviral agent approved for suppression of chronic hepatitis D but requiring further research into optimising the treatment scheme.Aim. Comparative assessment of bulevirtide monotherapy versus combined treatment with bulevirtide and pegylat-ed interferon (PEG-IFN) using publi...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado: |
Gastro LLC
2020-09-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Assuntos: | |
| Acceso en liña: | https://www.gastro-j.ru/jour/article/view/489 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|